FDA

News and Updates by the Food and Drugs Administration (FDA)

Molbio Empowers Azerbaijan’s Eco-Friendly TB Initiative at COP29 with Cutting-Edge Diagnostic Support

In a strategic push to address tuberculosis (TB) while considering the impacts of climate change, Molbio Diagnostics, a pioneer in global healthcare innovation, has made a significant donation of advanced TB screening and diagnostic tools to Azerbaijan’s Ministry of Health. […]

Molbio Empowers Azerbaijan’s Eco-Friendly TB Initiative at COP29 with Cutting-Edge Diagnostic Support Read More »

China NMPA Grants Priority Review for Ascentage Pharma’s Lisaftoclax, a Novel Bcl-2 Inhibitor for r/r CLL/SLL

Ascentage Pharma, an international biopharmaceutical company dedicated to discovering, developing, and commercializing innovative treatments addressing worldwide unmet medical needs, particularly in cancer, has announced that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has accepted

China NMPA Grants Priority Review for Ascentage Pharma’s Lisaftoclax, a Novel Bcl-2 Inhibitor for r/r CLL/SLL Read More »